Skip to main content
Livermore
Livermore
ZHEN

BLB&B Advisors, LLC

SEC CIK
0001389059
Latest filing
Aug 5, 2026

GSK holding history

GSK plc in every 13F filed by BLB&B Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
5,756
Value
$301.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of GSK by BLB&B Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,756$301.7K<0.1%−93−1.6%ReducedHolders
Q1 20265,849$322.8K<0.1%+69+1.2%AddedHolders
Q4 20255,780$283.4K<0.1%−207−3.5%ReducedHolders
Q3 20255,987$258.4K<0.1%00.0%UnchangedHolders
Q2 20255,987$229.9K<0.1%+173+3.0%AddedHolders
Q1 20255,814$225.2K<0.1%+5,814NewHolders
Q4 20240$00.0%−6,131−100.0%Sold outHolders
Q3 20246,131$250.6K<0.1%00.0%UnchangedHolders
Q2 20246,131$236.0K<0.1%00.0%UnchangedHolders
Q1 20246,131$262.8K<0.1%−240−3.8%ReducedHolders
Q4 20236,371$236.1K<0.1%−105−1.6%ReducedHolders
Q3 20236,476$234.8K<0.1%−196−2.9%ReducedHolders
Q2 20236,672$237.8K<0.1%−476−6.7%ReducedHolders
Q1 20237,148$254.3K<0.1%−9,221−56.3%ReducedHolders
Q4 202216,369$575.2K<0.1%+8,226+101.0%AddedHolders
Q3 20228,143$240.0K<0.1%−2,337−22.3%ReducedHolders
Q2 202210,480$456.0K<0.1%−835−7.4%ReducedHolders
Q1 202211,315$493.0K<0.1%−992−8.1%ReducedHolders
Q4 202112,307$543.0K<0.1%−3,004−19.6%ReducedHolders
Q3 202115,311$585.0K<0.1%+1,420+10.2%AddedHolders
Q2 202113,891$553.0K<0.1%−4,431−24.2%ReducedHolders
Q1 202118,322$654.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.